Meningococcal Vaccines Market

Meningococcal Vaccines Market - Global Industry Assessment & Forecast

Healthcare

# Pages:

200

Base Year:

2023

Jun - 2024

Format:

Report Code:

VMR-2489

Segments Covered

By Type Polysaccharide Vaccines, Conjugate Vaccines, Combination Vaccines
By Age Group Infants (0 to 2 Years), Children & Adults (2 Years & Above)
By Serotype Serotype A, Serotype B, Serotype C, Serotype W-135, Serotype Y
By Distribution Channel Hospital Pharmacies, Retail Pharmacies, Others (Online Pharmacies, Drug Stores)
By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Standard License

$ 4299 USD

Multi User License

$ 6599 USD

Enterprise License

$ 6999 USD

Snapshot

Base Year:	2023
Forecast Years:	2024 - 2032
Historical Years:	2018 - 2022
Revenue 2023:	USD 3.61 Billion
Revenue 2032:	USD 6.35 Billion
Revenue CAGR (2024 - 2032):	6.5%
Fastest Growing Region (2024 - 2032)	Asia Pacific
Largest Region (2023):	North America

Customization Offered

Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market Dynamics
Region Level Market Share
Import Export Analysis
Production Analysis
Others Request Customization Speak To Analyst

Executive Dashboard
1. Strategic Imperatives
Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Global Meningococcal Vaccines Market - Segment Analysis
1. Overview
2. Global Meningococcal Vaccines Market, 2016 - 2028 (USD Million)
3. Global Meningococcal Vaccines Market - by Type
  1. By Polysaccharide Vaccines
  2. By Conjugate Vaccines
  3. By Combination Vaccines
4. Global Meningococcal Vaccines Market - by Age Group
  1. By Infants (0 to 2 Years)
  2. By Children & Adults (2 Years & Above)
5. Global Meningococcal Vaccines Market - by Serotype
  1. By Serotype A
  2. By Serotype B
  3. By Serotype C
  4. By Serotype W-135
  5. By Serotype Y
6. Global Meningococcal Vaccines Market - by Distribution Channel
  1. By Hospital Pharmacies
  2. By Retail Pharmacies
  3. By Others (Online Pharmacies, Drug Stores)
7. Global Meningococcal Vaccines Market - by region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
8. Market comparative analysis
North America Meningococcal Vaccines Market - Segment Analysis
1. Overview
2. North America Meningococcal Vaccines Market, 2016 - 2028 (USD Million)
3. North America Meningococcal Vaccines Market, by Type
  1. By Polysaccharide Vaccines
  2. By Conjugate Vaccines
  3. By Combination Vaccines
4. North America Meningococcal Vaccines Market, by Age Group
  1. By Infants (0 to 2 Years)
  2. By Children & Adults (2 Years & Above)
5. North America Meningococcal Vaccines Market, by Serotype
  1. By Serotype A
  2. By Serotype B
  3. By Serotype C
  4. By Serotype W-135
  5. By Serotype Y
6. North America Meningococcal Vaccines Market, by Distribution Channel
  1. By Hospital Pharmacies
  2. By Retail Pharmacies
  3. By Others (Online Pharmacies, Drug Stores)
7. North America Meningococcal Vaccines Market, by Country
  1. U.S.
    1. U.S. Meningococcal Vaccines Market, By Type
      1. By Polysaccharide Vaccines
      2. By Conjugate Vaccines
      3. By Combination Vaccines
    2. U.S. Meningococcal Vaccines Market, By Age Group
      1. By Infants (0 to 2 Years)
      2. By Children & Adults (2 Years & Above)
    3. U.S. Meningococcal Vaccines Market, By Serotype
      1. By Serotype A
      2. By Serotype B
      3. By Serotype C
      4. By Serotype W-135
      5. By Serotype Y
    4. U.S. Meningococcal Vaccines Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Others (Online Pharmacies, Drug Stores)
  2. Canada
    1. Canada Meningococcal Vaccines Market, By Type
      1. By Polysaccharide Vaccines
      2. By Conjugate Vaccines
      3. By Combination Vaccines
    2. Canada Meningococcal Vaccines Market, By Age Group
      1. By Infants (0 to 2 Years)
      2. By Children & Adults (2 Years & Above)
    3. Canada Meningococcal Vaccines Market, By Serotype
      1. By Serotype A
      2. By Serotype B
      3. By Serotype C
      4. By Serotype W-135
      5. By Serotype Y
    4. Canada Meningococcal Vaccines Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Others (Online Pharmacies, Drug Stores)
  3. Mexico
    1. Mexico Meningococcal Vaccines Market, By Type
      1. By Polysaccharide Vaccines
      2. By Conjugate Vaccines
      3. By Combination Vaccines
    2. Mexico Meningococcal Vaccines Market, By Age Group
      1. By Infants (0 to 2 Years)
      2. By Children & Adults (2 Years & Above)
    3. Mexico Meningococcal Vaccines Market, By Serotype
      1. By Serotype A
      2. By Serotype B
      3. By Serotype C
      4. By Serotype W-135
      5. By Serotype Y
    4. Mexico Meningococcal Vaccines Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Others (Online Pharmacies, Drug Stores)
Europe Meningococcal Vaccines Market - Segment Analysis
1. Overview
2. Europe Meningococcal Vaccines Market, 2016 - 2028 (USD Million)
3. Europe Meningococcal Vaccines Market, by Type
  1. By Polysaccharide Vaccines
  2. By Conjugate Vaccines
  3. By Combination Vaccines
4. Europe Meningococcal Vaccines Market, by Age Group
  1. By Infants (0 to 2 Years)
  2. By Children & Adults (2 Years & Above)
5. Europe Meningococcal Vaccines Market, by Serotype
  1. By Serotype A
  2. By Serotype B
  3. By Serotype C
  4. By Serotype W-135
  5. By Serotype Y
6. Europe Meningococcal Vaccines Market, by Distribution Channel
  1. By Hospital Pharmacies
  2. By Retail Pharmacies
  3. By Others (Online Pharmacies, Drug Stores)
7. Europe Meningococcal Vaccines Market, by Country
  1. Germany
    1. Germany Meningococcal Vaccines Market, By Type
      1. By Polysaccharide Vaccines
      2. By Conjugate Vaccines
      3. By Combination Vaccines
    2. Germany Meningococcal Vaccines Market, By Age Group
      1. By Infants (0 to 2 Years)
      2. By Children & Adults (2 Years & Above)
    3. Germany Meningococcal Vaccines Market, By Serotype
      1. By Serotype A
      2. By Serotype B
      3. By Serotype C
      4. By Serotype W-135
      5. By Serotype Y
    4. Germany Meningococcal Vaccines Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Others (Online Pharmacies, Drug Stores)
  2. UK
    1. UK Market, By Type
      1. By Polysaccharide Vaccines
      2. By Conjugate Vaccines
      3. By Combination Vaccines
    2. UK Market, By Age Group
      1. By Infants (0 to 2 Years)
      2. By Children & Adults (2 Years & Above)
    3. UK Market, By Serotype
      1. By Serotype A
      2. By Serotype B
      3. By Serotype C
      4. By Serotype W-135
      5. By Serotype Y
    4. UK Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Others (Online Pharmacies, Drug Stores)
  3. France
    1. France Meningococcal Vaccines Market, By Type
      1. By Polysaccharide Vaccines
      2. By Conjugate Vaccines
      3. By Combination Vaccines
    2. France Meningococcal Vaccines Market, By Age Group
      1. By Infants (0 to 2 Years)
      2. By Children & Adults (2 Years & Above)
    3. France Meningococcal Vaccines Market, By Serotype
      1. By Serotype A
      2. By Serotype B
      3. By Serotype C
      4. By Serotype W-135
      5. By Serotype Y
    4. France Meningococcal Vaccines Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Others (Online Pharmacies, Drug Stores)
  4. Spain
    1. Spain Meningococcal Vaccines Market, By Type
      1. By Polysaccharide Vaccines
      2. By Conjugate Vaccines
      3. By Combination Vaccines
    2. Spain Meningococcal Vaccines Market, By Age Group
      1. By Infants (0 to 2 Years)
      2. By Children & Adults (2 Years & Above)
    3. Spain Meningococcal Vaccines Market, By Serotype
      1. By Serotype A
      2. By Serotype B
      3. By Serotype C
      4. By Serotype W-135
      5. By Serotype Y
    4. Spain Meningococcal Vaccines Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Others (Online Pharmacies, Drug Stores)
  5. Italy
    1. Italy Meningococcal Vaccines Market, By Type
      1. By Polysaccharide Vaccines
      2. By Conjugate Vaccines
      3. By Combination Vaccines
    2. Italy Meningococcal Vaccines Market, By Age Group
      1. By Infants (0 to 2 Years)
      2. By Children & Adults (2 Years & Above)
    3. Italy Meningococcal Vaccines Market, By Serotype
      1. By Serotype A
      2. By Serotype B
      3. By Serotype C
      4. By Serotype W-135
      5. By Serotype Y
    4. Italy Meningococcal Vaccines Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Others (Online Pharmacies, Drug Stores)
  6. BENELUX
    1. BENELUX Meningococcal Vaccines Market, By Type
      1. By Polysaccharide Vaccines
      2. By Conjugate Vaccines
      3. By Combination Vaccines
    2. BENELUX Meningococcal Vaccines Market, By Age Group
      1. By Infants (0 to 2 Years)
      2. By Children & Adults (2 Years & Above)
    3. BENELUX Meningococcal Vaccines Market, By Serotype
      1. By Serotype A
      2. By Serotype B
      3. By Serotype C
      4. By Serotype W-135
      5. By Serotype Y
    4. BENELUX Meningococcal Vaccines Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Others (Online Pharmacies, Drug Stores)
  7. Rest of Europe
    1. Rest Of Europe Meningococcal Vaccines Market, By Type
      1. By Polysaccharide Vaccines
      2. By Conjugate Vaccines
      3. By Combination Vaccines
    2. Rest Of Europe Meningococcal Vaccines Market, By Age Group
      1. By Infants (0 to 2 Years)
      2. By Children & Adults (2 Years & Above)
    3. Rest Of Europe Meningococcal Vaccines Market, By Serotype
      1. By Serotype A
      2. By Serotype B
      3. By Serotype C
      4. By Serotype W-135
      5. By Serotype Y
    4. Rest Of Europe Meningococcal Vaccines Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Others (Online Pharmacies, Drug Stores)
Asia Pacific Meningococcal Vaccines Market - Segment Analysis
1. Overview
2. Asia Pacific Meningococcal Vaccines Market, 2016 - 2028 (USD Million)
3. Asia Pacific Meningococcal Vaccines Market, by Type
  1. By Polysaccharide Vaccines
  2. By Conjugate Vaccines
  3. By Combination Vaccines
4. Asia Pacific Meningococcal Vaccines Market, by Age Group
  1. By Infants (0 to 2 Years)
  2. By Children & Adults (2 Years & Above)
5. Asia Pacific Meningococcal Vaccines Market, by Serotype
  1. By Serotype A
  2. By Serotype B
  3. By Serotype C
  4. By Serotype W-135
  5. By Serotype Y
6. Asia Pacific Meningococcal Vaccines Market, by Distribution Channel
  1. By Hospital Pharmacies
  2. By Retail Pharmacies
  3. By Others (Online Pharmacies, Drug Stores)
7. Asia Pacific Meningococcal Vaccines Market, by Country
  1. China
    1. China Meningococcal Vaccines Market, By Type
      1. By Polysaccharide Vaccines
      2. By Conjugate Vaccines
      3. By Combination Vaccines
    2. China Meningococcal Vaccines Market, By Age Group
      1. By Infants (0 to 2 Years)
      2. By Children & Adults (2 Years & Above)
    3. China Meningococcal Vaccines Market, By Serotype
      1. By Serotype A
      2. By Serotype B
      3. By Serotype C
      4. By Serotype W-135
      5. By Serotype Y
    4. China Meningococcal Vaccines Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Others (Online Pharmacies, Drug Stores)
  2. Japan
    1. Japan Meningococcal Vaccines Market, By Type
      1. By Polysaccharide Vaccines
      2. By Conjugate Vaccines
      3. By Combination Vaccines
    2. Japan Meningococcal Vaccines Market, By Age Group
      1. By Infants (0 to 2 Years)
      2. By Children & Adults (2 Years & Above)
    3. Japan Meningococcal Vaccines Market, By Serotype
      1. By Serotype A
      2. By Serotype B
      3. By Serotype C
      4. By Serotype W-135
      5. By Serotype Y
    4. Japan Meningococcal Vaccines Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Others (Online Pharmacies, Drug Stores)
  3. India
    1. India Meningococcal Vaccines Market, By Type
      1. By Polysaccharide Vaccines
      2. By Conjugate Vaccines
      3. By Combination Vaccines
    2. India Meningococcal Vaccines Market, By Age Group
      1. By Infants (0 to 2 Years)
      2. By Children & Adults (2 Years & Above)
    3. India Meningococcal Vaccines Market, By Serotype
      1. By Serotype A
      2. By Serotype B
      3. By Serotype C
      4. By Serotype W-135
      5. By Serotype Y
    4. India Meningococcal Vaccines Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Others (Online Pharmacies, Drug Stores)
  4. South Korea
    1. South Korea Meningococcal Vaccines Market, By Type
      1. By Polysaccharide Vaccines
      2. By Conjugate Vaccines
      3. By Combination Vaccines
    2. South Korea Meningococcal Vaccines Market, By Age Group
      1. By Infants (0 to 2 Years)
      2. By Children & Adults (2 Years & Above)
    3. South Korea Meningococcal Vaccines Market, By Serotype
      1. By Serotype A
      2. By Serotype B
      3. By Serotype C
      4. By Serotype W-135
      5. By Serotype Y
    4. South Korea Meningococcal Vaccines Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Others (Online Pharmacies, Drug Stores)
  5. South East Asia
    1. South East Asia Meningococcal Vaccines Market, By Type
      1. By Polysaccharide Vaccines
      2. By Conjugate Vaccines
      3. By Combination Vaccines
    2. South East Asia Meningococcal Vaccines Market, By Age Group
      1. By Infants (0 to 2 Years)
      2. By Children & Adults (2 Years & Above)
    3. South East Asia Meningococcal Vaccines Market, By Serotype
      1. By Serotype A
      2. By Serotype B
      3. By Serotype C
      4. By Serotype W-135
      5. By Serotype Y
    4. South East Asia Meningococcal Vaccines Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Others (Online Pharmacies, Drug Stores)
  6. Rest of Asia Pacific
    1. Rest of Asia Pacific Meningococcal Vaccines Market, By Type
      1. By Polysaccharide Vaccines
      2. By Conjugate Vaccines
      3. By Combination Vaccines
    2. Rest of Asia Pacific Meningococcal Vaccines Market, By Age Group
      1. By Infants (0 to 2 Years)
      2. By Children & Adults (2 Years & Above)
    3. Rest of Asia Pacific Meningococcal Vaccines Market, By Serotype
      1. By Serotype A
      2. By Serotype B
      3. By Serotype C
      4. By Serotype W-135
      5. By Serotype Y
    4. Rest of Asia Pacific Meningococcal Vaccines Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Others (Online Pharmacies, Drug Stores)
Latin America Meningococcal Vaccines Market - Segment Analysis
1. Overview
2. Latin America Meningococcal Vaccines Market, 2016 - 2028 (USD Million)
3. Latin America Meningococcal Vaccines Market, by Type
  1. By Polysaccharide Vaccines
  2. By Conjugate Vaccines
  3. By Combination Vaccines
4. Latin America Meningococcal Vaccines Market, by Age Group
  1. By Infants (0 to 2 Years)
  2. By Children & Adults (2 Years & Above)
5. Latin America Meningococcal Vaccines Market, by Serotype
  1. By Serotype A
  2. By Serotype B
  3. By Serotype C
  4. By Serotype W-135
  5. By Serotype Y
6. Latin America Meningococcal Vaccines Market, by Distribution Channel
  1. By Hospital Pharmacies
  2. By Retail Pharmacies
  3. By Others (Online Pharmacies, Drug Stores)
7. Latin America Meningococcal Vaccines Market, by Country
  1. Brazil
    1. Brazil Meningococcal Vaccines Market, By Type
      1. By Polysaccharide Vaccines
      2. By Conjugate Vaccines
      3. By Combination Vaccines
    2. Brazil Meningococcal Vaccines Market, By Age Group
      1. By Infants (0 to 2 Years)
      2. By Children & Adults (2 Years & Above)
    3. Brazil Meningococcal Vaccines Market, By Serotype
      1. By Serotype A
      2. By Serotype B
      3. By Serotype C
      4. By Serotype W-135
      5. By Serotype Y
    4. Brazil Meningococcal Vaccines Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Others (Online Pharmacies, Drug Stores)
  2. Argentina
    1. Argentina Meningococcal Vaccines Market, By Type
      1. By Polysaccharide Vaccines
      2. By Conjugate Vaccines
      3. By Combination Vaccines
    2. Argentina Meningococcal Vaccines Market, By Age Group
      1. By Infants (0 to 2 Years)
      2. By Children & Adults (2 Years & Above)
    3. Argentina Meningococcal Vaccines Market, By Serotype
      1. By Serotype A
      2. By Serotype B
      3. By Serotype C
      4. By Serotype W-135
      5. By Serotype Y
    4. Argentina Meningococcal Vaccines Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Others (Online Pharmacies, Drug Stores)
  3. Rest of Latin America
    1. Rest of Latin America Meningococcal Vaccines Market, By Type
      1. By Polysaccharide Vaccines
      2. By Conjugate Vaccines
      3. By Combination Vaccines
    2. Rest of Latin America Meningococcal Vaccines Market, By Age Group
      1. By Infants (0 to 2 Years)
      2. By Children & Adults (2 Years & Above)
    3. Rest of Latin America Meningococcal Vaccines Market, By Serotype
      1. By Serotype A
      2. By Serotype B
      3. By Serotype C
      4. By Serotype W-135
      5. By Serotype Y
    4. Rest of Latin America Meningococcal Vaccines Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Others (Online Pharmacies, Drug Stores)
Middle East & Africa Meningococcal Vaccines Market - Segment Analysis
1. Overview
2. Middle East & Africa Meningococcal Vaccines Market, 2016 - 2028 (USD Million)
3. Middle East & Africa Meningococcal Vaccines Market, by Type
  1. By Polysaccharide Vaccines
  2. By Conjugate Vaccines
  3. By Combination Vaccines
4. Middle East & Africa Meningococcal Vaccines Market, by Age Group
  1. By Infants (0 to 2 Years)
  2. By Children & Adults (2 Years & Above)
5. Middle East & Africa Meningococcal Vaccines Market, by Serotype
  1. By Serotype A
  2. By Serotype B
  3. By Serotype C
  4. By Serotype W-135
  5. By Serotype Y
6. Middle East & Africa Meningococcal Vaccines Market, by Distribution Channel
  1. By Hospital Pharmacies
  2. By Retail Pharmacies
  3. By Others (Online Pharmacies, Drug Stores)
7. Middle East & Africa Meningococcal Vaccines Market, by Country
  1. GCC Countries
    1. GCC Countries Meningococcal Vaccines Market, By Type
      1. By Polysaccharide Vaccines
      2. By Conjugate Vaccines
      3. By Combination Vaccines
    2. GCC Countries Meningococcal Vaccines Market, By Age Group
      1. By Infants (0 to 2 Years)
      2. By Children & Adults (2 Years & Above)
    3. GCC Countries Meningococcal Vaccines Market, By Serotype
      1. By Serotype A
      2. By Serotype B
      3. By Serotype C
      4. By Serotype W-135
      5. By Serotype Y
    4. GCC Countries Meningococcal Vaccines Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Others (Online Pharmacies, Drug Stores)
  2. South Africa
    1. South Africa Meningococcal Vaccines Market, By Type
      1. By Polysaccharide Vaccines
      2. By Conjugate Vaccines
      3. By Combination Vaccines
    2. South Africa Meningococcal Vaccines Market, By Age Group
      1. By Infants (0 to 2 Years)
      2. By Children & Adults (2 Years & Above)
    3. South Africa Meningococcal Vaccines Market, By Serotype
      1. By Serotype A
      2. By Serotype B
      3. By Serotype C
      4. By Serotype W-135
      5. By Serotype Y
    4. South Africa Meningococcal Vaccines Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Others (Online Pharmacies, Drug Stores)
  3. Rest of Middle East & Africa
    1. Rest of Middle East & Africa Meningococcal Vaccines Market, By Type
      1. By Polysaccharide Vaccines
      2. By Conjugate Vaccines
      3. By Combination Vaccines
    2. Rest of Middle East & Africa Meningococcal Vaccines Market, By Age Group
      1. By Infants (0 to 2 Years)
      2. By Children & Adults (2 Years & Above)
    3. Rest of Middle East & Africa Meningococcal Vaccines Market, By Serotype
      1. By Serotype A
      2. By Serotype B
      3. By Serotype C
      4. By Serotype W-135
      5. By Serotype Y
    4. Rest of Middle East & Africa Meningococcal Vaccines Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Others (Online Pharmacies, Drug Stores)
Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Marketing Stratagy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Competative Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Company Profiles
1. Merck & Co. Inc. (U.S.)
2. Pfizer Inc. (U.S.)
3. Serum Institute of India Pvt. Ltd. (India)
4. Sanofi (France)
5. GSK PLC (UK)
6. Walvax Biotechnology Co. Ltd. (China)
7. Novartis AG (Switzerland)
8. Hualan Biological Engineering Inc. (China) Inc.pta Pharmaceuticals Limited (Bangladesh)
9. Bio-Med (P) Limited (India)
Key Primary Respondents - VERBATIM
Discussion Guide
Customization Offered
Annexure
List of Figures
List of Tables
List of Abbreviations

Vantage Market Research | 07-Jun-2024

GSK's 5-in-1 Meningococcal Vaccine Progresses in Regulatory Review

FAQ

Frequently Asked Question

What is the global demand for Meningococcal Vaccines in terms of revenue?

The global Meningococcal Vaccines valued at USD 3.61 Billion in 2023 and is expected to reach USD 6.35 Billion in 2032 growing at a CAGR of 6.5%.

Which are the prominent players in the market?

The prominent players in the market are Merck & Co. Inc. (U.S.), Pfizer Inc. (U.S.), Serum Institute of India Pvt. Ltd. (India), Sanofi (France), GSK PLC (UK), Walvax Biotechnology Co. Ltd. (China), Novartis AG (Switzerland), Hualan Biological Engineering Inc. (China), Incepta Pharmaceuticals Limited (Bangladesh), Bio-Med (P) Limited (India).

At what CAGR is the market projected to grow within the forecast period?

The market is project to grow at a CAGR of 6.5% between 2024 and 2032.

What are the driving factors fueling the growth of the market.

The driving factors of the Meningococcal Vaccines include

Which region accounted for the largest share in the market?

North America was the leading regional segment of the Meningococcal Vaccines in 2023.

Meningococcal Vaccines Market

Meningococcal Vaccines Market - Global Industry Assessment & Forecast

Healthcare

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Meningococcal Vaccines in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Quick Links

For Buying Inquiry

Meningococcal Vaccines Market

Meningococcal Vaccines Market - Global Industry Assessment & Forecast

Healthcare

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Meningococcal Vaccines in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Related Reports

Request Sample Report for Meningococcal Vaccines Market

Vantage Point Interactive Dashboard